Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksN4 Pharma Plc Regulatory News (N4P)

Share Price Information for N4 Pharma Plc (N4P)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.80
Bid: 0.75
Ask: 0.85
Change: 0.00 (0.00%)
Spread: 0.10 (13.333%)
Open: 0.80
High: 0.80
Low: 0.80
Prev. Close: 0.80
N4P Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

8 Jan 2024 16:24

RNS Number : 9988Y
N4 Pharma PLC
08 January 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BYW8QM32

Issuer Name

N4 PHARMA PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

An acquisition or disposal of voting rights

3. Details of person subject to the notification obligation

Name

IG Markets Limited

City of registered office (if applicable)

London

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

05-Jan-2024

6. Date on which Issuer notified

08-Jan-2024

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

0.000000

3.208694

3.208694

8624339

Position of previous notification (if applicable)

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

 

Sub Total 8.A

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

Equity swaps

Cash

8624339

3.208694

Sub Total 8.B2

8624339

3.208694%

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

IG Group Holdings

IG Markets Limited

3.208694

3.208694%

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

IG Markets Limited ('IGM') is a subsidiary of IG Group, the ultimate controlling person of which is IG Group Holdings plc. ('IGGH')IGM is 100% owned by IGGH through its subsidiaries, IG Group Ltd ('IGGL'), and Market Data Limited ('MDL').

12. Date of Completion

08-Jan-2024

13. Place Of Completion

London

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLFLFFRLVITIIS
Date   Source Headline
11th Nov 202011:05 amRNSSecond Price Monitoring Extn
11th Nov 202011:00 amRNSPrice Monitoring Extension
9th Nov 20207:00 amRNSLaunch of Nuvec® Oncology Treatment Programme
5th Nov 20207:00 amRNSOperational Update
30th Sep 20207:00 amRNSTotal Voting Rights
17th Sep 20207:00 amRNSInterim Results
15th Sep 20202:06 pmRNSSecond Price Monitoring Extn
15th Sep 20202:01 pmRNSPrice Monitoring Extension
14th Sep 202011:05 amRNSSecond Price Monitoring Extn
14th Sep 202011:00 amRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSCovid-19 Proof of Concept Update
8th Sep 202011:40 amRNSExercise of Options
2nd Sep 20208:00 amRNSHolding(s) in Company
2nd Sep 20208:00 amRNSTotal Voting Rights
1st Sep 20207:00 amRNSTechnology Transfer and Manufacturing Contract
26th Aug 20203:47 pmRNSExercise of Warrants and Issue of Equity
14th Aug 20202:22 pmRNSExercise of Warrants and Issue of Equity
14th Aug 202011:06 amRNSSecond Price Monitoring Extn
14th Aug 202011:00 amRNSPrice Monitoring Extension
12th Aug 20202:00 pmRNSPrice Monitoring Extension
12th Aug 20201:47 pmRNSPositive Covid-19 In Vitro Study Results
27th Jul 202011:05 amRNSSecond Price Monitoring Extn
27th Jul 202011:00 amRNSPrice Monitoring Extension
21st Jul 202011:00 amRNSPrice Monitoring Extension
15th Jul 20207:00 amRNSChange of Adviser
6th Jul 20207:00 amRNSWork Programme and Strategic Update
18th Jun 202012:05 pmRNSResult of General Meeting and grant of warrants
1st Jun 202012:28 pmRNSPosting of circular and notice of general meeting
29th May 20205:00 pmRNSTotal Voting Rights
28th May 20209:00 amRNSPrice Monitoring Extension
28th May 20207:00 amRNSCovid-19 Project Update
21st May 20204:26 pmRNSHolding(s) in Company
20th May 202012:29 pmRNSHolding(s) in Company
18th May 20204:41 pmRNSSecond Price Monitoring Extn
18th May 20204:37 pmRNSPrice Monitoring Extension
18th May 20204:29 pmRNSGrant of Options
18th May 20202:25 pmRNSPatent filing update
13th May 20201:58 pmRNSPlacing to raise £2m & appointment of Joint Broker
24th Apr 20207:00 amRNSNew Nuvec® opportunity and patent filing
23rd Apr 202011:01 amRNSResult of AGM
17th Apr 20207:00 amRNSAttendance at the Company's annual general meeting
16th Apr 20207:00 amRNSCovid-19 Project Update
15th Apr 20209:05 amRNSSecond Price Monitoring Extn
15th Apr 20209:00 amRNSPrice Monitoring Extension
30th Mar 20202:05 pmRNSSecond Price Monitoring Extn
30th Mar 20202:00 pmRNSPrice Monitoring Extension
25th Mar 20201:18 pmRNSChanges to AGM
25th Mar 20207:00 amRNSCovid-19 Project Update and operational update
16th Mar 202010:26 amRNSHolding(s) in Company
4th Mar 20207:00 amRNSPosting of Annual Report and Notice of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.